• FirefoxInstall the new Firefox »
  •  Dow Up0.22% Nasdaq Up0.39%

    More On NRI.TO

    Nuvo Research Inc. (NRI.TO)

    4.15 Up 0.05(1.22%) 9:35AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Nuvo Research Inc.
    7560 Airport Road
    Unit 10
    Mississauga, ON L4T 4H4
    Canada - Map
    Phone: 905-673-6980
    Fax: 905-673-1842
    Website: http://www.nuvoresearch.com

    Index Membership:N/A
    Full Time Employees:66

    Business Summary 

    Nuvo Research Inc., a specialty pharmaceutical company, researches, develops, and commercializes pharmaceutical products in Europe, Asia, and South America. The company focuses on the development and commercialization of topically delivered pain products. Its topical pain products include Pennsaid, a non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms associated with knee osteoarthritis; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of pain of knee osteoarthritis; Synera, a topical patch that provides local dermal analgesia for superficial venous access and superficial dermatological procedures; and Pliaglis, a topical local anaesthetic cream, which provides local dermal anaesthesia on intact skin prior to superficial dermatological procedures, such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. The company’s immunology products comprise WF10, a solution of OXO-K993 that focuses on supporting the immune system; and Oxoferin, a diluted form of WF10, which is a topical wound healing agent. The company was formerly known as Dimethaid Research Inc. and changed its name to Nuvo Research Inc. in September 2005. The company was founded in 1983 and is based in Mississauga, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Nuvo Research Inc.

    Key Executives 
    Mr. Daniel N. Chicoine B.Comm., CPA, C.A.,
    Exec. Chairman and Co-Chief Exec. Officer
    Mr. John C. London LLB, LLM,
    Co-Chief Exec. Officer, Pres and Director
    Mr. Stephen L. Lemieux BA, MMPA, CPA, CA,
    Chief Financial Officer and VP
    Ms. Katina K. Loucaides M.Sc., LL.B,
    VP, Gen. Counsel and Corp. Sec.
    Dr. Henrich R. K. Guntermann M.D., M.Sc,
    Director and Pres of Europe & Immunology Group
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.
    View Insiders